NEW YORK, NY / ACCESS Newswire / May 9, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amerant Bancorp Inc. ("Amerant" or "the Company") (NYSE:AMTB). Investors who purchased Amerant securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AMTB.
Investigation Details
On April 23, 2025, Amerant reported its financial results for Q1 2025. The Company's earnings per share missed consensus estimates by a wide margin. Amerant's Chairman and CEO said that "loans were relatively flat quarter over quarter, as a result of increased payoffs and paydowns offsetting production in the first quarter." Following this news, Amerant stock dropped more than 13% the next day.
What's Next?
If you are aware of any facts relating to this investigation or purchased Amerant securities, you can assist this investigation by visiting the firm's site: bgandg.com/AMTB. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original
press release on ACCESS Newswire
